Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Bristol-Myers Squibb Company, 3 years.
Bristol-Myers Squibb Company
Director
DaVita Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 15, 2025 | DaVita Inc. | Grant or award | +349 | — | — |
| Dec 2, 2024 | DaVita Inc. | Gift | −3,500 | — | — |
| Nov 15, 2024 | DaVita Inc. | Grant or award | +312 | — | — |
| Aug 15, 2024 | DaVita Inc. | Grant or award | +333 | — | — |
| May 15, 2024 | DaVita Inc. | Grant or award | +363 | — | — |
| Mar 15, 2024 | DaVita Inc. | Grant or award | +366 | — | — |
| Nov 15, 2023 | DaVita Inc. | Grant or award | +529 | — | — |
| Aug 15, 2023 | DaVita Inc. | Grant or award | +475 | — | — |
| May 15, 2023 | DaVita Inc. | Grant or award | +516 | — | — |
| May 12, 2023 | DaVita Inc. | Option exercise | +7,165 | $66.29 | $474,968 |
| May 12, 2023 | DaVita Inc. | Sold back to the company | −4,969 | $95.59 | $474,987 |
| May 12, 2023 | DaVita Inc. | Open-market sale | −2,196 | $95.26 | $209,191 |
| Mar 15, 2023 | DaVita Inc. | Grant or award | +658 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.